EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis

Mei Wang, Siyi Hu, Jiawang Yang, Liang Yuan, Limin Han, Feng Liang, Fenglin Zhang, Hailong Zhao, Yun Liu, Ning Gao

Phytomedicine · 2024-05 · 127 · 155391

DOI: 10.1016/j.phymed.2024.155391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-05. Verfasst von Mei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Bufanolides, Lung Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zunyi Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer (CRC) is one of the commonest cancers worldwide. Metastasis is the most common cause of death in patients with CRC. Arenobufagin is an active component of bufadienolides, extracted from toad skin and parotid venom. Arenobufagin reportedly inhibits epithelial-to-mesenchymal transition (EMT) and metastasis in various cancers. However, the mechanism through which arenobufagin inhibits CRC metastasis remains unclear. PURPOSE: This study aimed to elucidate the molecular mechanisms by which arenobufagin inhibits CRC metastasis. METHODS: Wound-healing and transwell assays were used to assess the migration and invasion of CRC cells. The expression of nuclear factor erythroid-2-related factor 2 (Nrf2) in the CRC tissues was assessed using immunohistochemistry. The protein expression levels of c-MYC and Nrf2 were detected by immunoblotting. A mouse model of lung metastasis was used to study the effects of arenobufagin on CRC lung metastasis in vivo. RESULTS: Arenobufagin observably inhibited the migration and invasion of CRC cells by downregulating c-MYC and inactivating the Nrf2 signaling pathway. Pretreatment with the Nrf2 inhibitor brusatol markedly enhanced arenobufagin-mediated inhibition of migration and invasion, whereas pretreatment with the Nrf2 agonist tert‑butylhydroquinone significantly attenuated arenobufagin-mediated inhibition of migration and invasion of CRC cells. Furthermore, Nrf2 knockdown with short hairpin RNA enhanced the arenobufagin-induced inhibition of the migration and invasion of CRC cells. Importantly, c-MYC acts as an upstream modulator of Nrf2 in CRC cells. c-MYC knockdown markedly enhanced arenobufagin-mediated inhibition of the Nrf2 signaling pathway, cell migration, and invasion. Arenobufagin inhibited CRC lung metastasis in vivo. Together, these findings provide evidence that interruption of the c-MYC/Nrf2 signaling pathway is crucial for arenobufagin-inhibited cell metastasis in CRC. CONCLUSIONS: Collectively, our findings show that arenobufagin could be used as a potential anticancer agent against CRC metastasis. The arenobufagin-targeted c-MYC/Nrf2 signaling pathway may be a novel chemotherapeutic strategy for treating CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBufanolidesLung NeoplasmsAnimalsMiceHumansNF-E2-Related Factor 2Cell Line, TumorEpithelial-Mesenchymal TransitionCell MovementGene Expression Regulation, NeoplasticCell ProliferationNeoplasm Metastasis

Stichwörter der Autor:innen

ArenobufaginColorectal cancerMetastasisNrf2c-MYC

Substanzen

arenobufaginNF-E2-Related Factor 2Bufanolides

Autor:innen und Institutionen

  • Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, PR China.
  • Department of Pathophysiology, Zunyi Medical University, Zunyi 563000, Guizhou, PR China.
  • Department of Pathophysiology, Zunyi Medical University, Zunyi 563000, Guizhou, PR China. Electronic address: hailongzhao@zmu.edu.cn.
  • Guizhou Provincial College-based Key Laboratory for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, 563000, PR China. Electronic address: liuyunzmu@126.com.
  • Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, PR China. Electronic address:…

Förderung

  • Zunyi Medical College

Zitieren

APA

Wang, M., Hu, S., Yang, J., Yuan, L., Han, L., Liang, F., Zhang, F., Zhao, H., Liu, Y., & Gao, N. (2024). Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis. Phytomedicine, 127, 155391. https://doi.org/10.1016/j.phymed.2024.155391

Vancouver

Wang M, Hu S, Yang J, Yuan L, Han L, Liang F, et al. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis. Phytomedicine. 2024;127:155391. doi:10.1016/j.phymed.2024.155391

BibTeX
@article{Wang2024,
  author = {Wang, Mei and Hu, Siyi and Yang, Jiawang and Yuan, Liang and Han, Limin and Liang, Feng and Zhang, Fenglin and Zhao, Hailong and Liu, Yun and Gao, Ning},
  title = {Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis},
  journal = {Phytomedicine},
  year = {2024},
  volume = {127},
  pages = {155391},
  doi = {10.1016/j.phymed.2024.155391}
}
Kostenlos starten →